Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Insights, Forecast to 2025
- QYR2789054
- 114 Pages
- October 2018
- Medical Devices
This report studies the global market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices in these regions.
This research report categorizes the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market by top players/brands, region, type and end user. This report also studies the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Endo International (US)
Karl Storz (Germany)
Medtronic (US)
Siemens (Germany)
Lumenis (Israel)
Olympus (Japan)
Urologix (US)
NeoTract (US)
Boston Scientific (US)
Urotech (Germany)
Toshiba (Japan)
Baxter International (US)
Market size by Product
Laser Based Procedure
Other Energy Based Procedure
Market size by End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Benign Prostatic Hyperplasia (BPH) Treatment Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Benign Prostatic Hyperplasia (BPH) Treatment Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by Product
1.4.2 Laser Based Procedure
1.4.3 Other Energy Based Procedure
1.5 Market by End User
1.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialty Clinics
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2013-2025
2.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2013-2025
2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Growth Rate by Regions
2.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Regions
2.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers
3.1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers
3.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers
3.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Ratio (CR5 and HHI)
3.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturers
3.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturers (2013-2018)
3.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2013-2018)
3.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Manufacturers
3.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base Distribution, Product Types
3.4.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
3.4.3 Date of International Manufacturers Enter into Benign Prostatic Hyperplasia (BPH) Treatment Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Product
4.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Breakdown Data by End User
6 North America
6.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries
6.1.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries
6.1.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product
6.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User
7 Europe
7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries
7.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries
7.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product
7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User
8 Asia Pacific
8.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries
8.1.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries
8.1.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product
8.3 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User
9 Central & South America
9.1 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries
9.1.1 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries
9.1.2 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product
9.3 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User
10 Middle East and Africa
10.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries
10.1.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries
10.1.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product
10.3 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User
11 Company Profiles
11.1 Endo International (US)
11.1.1 Endo International (US) Company Details
11.1.2 Company Business Overview
11.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.1.5 Endo International (US) Recent Development
11.2 Karl Storz (Germany)
11.2.1 Karl Storz (Germany) Company Details
11.2.2 Company Business Overview
11.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.2.5 Karl Storz (Germany) Recent Development
11.3 Medtronic (US)
11.3.1 Medtronic (US) Company Details
11.3.2 Company Business Overview
11.3.Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.3.5 Medtronic (US) Recent Development
11.4 Siemens (Germany)
11.4.1 Siemens (Germany) Company Details
11.4.2 Company Business Overview
11.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.4.5 Siemens (Germany) Recent Development
11.5 Lumenis (Israel)
11.5.1 Lumenis (Israel) Company Details
11.5.2 Company Business Overview
11.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.5.5 Lumenis (Israel) Recent Development
11.6 Olympus (Japan)
11.6.1 Olympus (Japan) Company Details
11.6.2 Company Business Overview
11.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.6.5 Olympus (Japan) Recent Development
11.7 Urologix (US)
11.7.1 Urologix (US) Company Details
11.7.2 Company Business Overview
11.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.7.5 Urologix (US) Recent Development
11.8 NeoTract (US)
11.8.1 NeoTract (US) Company Details
11.8.2 Company Business Overview
11.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.8.4 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.8.5 NeoTract (US) Recent Development
11.9 Boston Scientific (US)
11.9.1 Boston Scientific (US) Company Details
11.9.2 Company Business Overview
11.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.9.5 Boston Scientific (US) Recent Development
11.10 Urotech (Germany)
11.10.1 Urotech (Germany) Company Details
11.10.2 Company Business Overview
11.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
11.10.5 Urotech (Germany) Recent Development
11.11 Toshiba (Japan)
11.12 Baxter International (US)
12 Future Forecast
12.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Regions
12.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Regions 2018-2025
12.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Regions 2018-2025
12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Product
12.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Product 2018-2025
12.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Product 2018-2025
12.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by End User
12.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast
12.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast
12.6 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast
12.7 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast
12.8 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Picture
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segments
Table Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Covered
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product 2013-2025
Figure Laser Based Procedure Product Picture
Table Major Manufacturers of Laser Based Procedure
Figure Other Energy Based Procedure Product Picture
Table Major Manufacturers of Other Energy Based Procedure
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospitals
Figure Ambulatory Surgical Centers
Figure Specialty Clinics
Figure Other
Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Report Years Considered
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size 2013-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2013-2025 (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Regions 2013-2018 (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018
Figure 2017 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Regions 2013-2018 (Million US$)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018
Figure 2017 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers (2013-2018) (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturers (2013-2018) (Million USD)
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2013-2018)
Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Value Share by Manufacturers in 2017
Table Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (2013-2018) (USD/Unit)
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
Table Date of International Manufacturers Enter into Benign Prostatic Hyperplasia (BPH) Treatment Devices Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Product (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Product (2013-2018) (Million US$)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Product (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Product (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Product in 2017
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Product 2013-2018 (USD/Unit)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by End User (2013-2018)
Figure Global Sales Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User (2013-2018)
Figure Global Sales Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User in 2017
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)
Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries
Figure United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)
Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)
Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries
Figure Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)
Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)
Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User
Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)
Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User
Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries
Figure Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)
Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries
Figure GCC Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User
Table Endo International (US) Company Details
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Endo International (US) Recent Development
Table Karl Storz (Germany) Company Details
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Karl Storz (Germany) Recent Development
Table Medtronic (US) Company Details
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medtronic (US) Recent Development
Table Siemens (Germany) Company Details
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Siemens (Germany) Recent Development
Table Lumenis (Israel) Company Details
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Lumenis (Israel) Recent Development
Table Olympus (Japan) Company Details
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Olympus (Japan) Recent Development
Table Urologix (US) Company Details
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Urologix (US) Recent Development
Table NeoTract (US) Company Details
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table NeoTract (US) Recent Development
Table Boston Scientific (US) Company Details
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Boston Scientific (US) Recent Development
Table Urotech (Germany) Company Details
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Urotech (Germany) Recent Development
Table Toshiba (Japan) Company Details
Table Baxter International (US) Company Details
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Regions 2018-2025 (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Regions 2018-2025
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Regions 2018-2025
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Product 2018-2025 (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Product 2018-2025
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Product 2018-2025
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by End User 2018-2025 (K Units)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by End User 2018-2025
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Value Chain
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers List
Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
